---
title: Peripheral Upregulation of Parkinson's Disease-Associated Genes Encoding α-Synuclein,
  β-Glucocerebrosidase, and Ceramide Glucosyltransferase in Major Depression
date: '2024-03-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38542193/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240328180704&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Due to the high comorbidity of Parkinson''s disease (PD) with major
  depressive disorder (MDD) and the involvement of sphingolipids in both conditions,
  we investigated the peripheral expression levels of three primarily PD-associated
  genes: α-synuclein (SNCA), lysosomal enzyme β-glucocerebrosidase (GBA1), and UDP-glucose
  ceramide glucosyltransferase (UGCG) in a sex-balanced MDD cohort. Normalized gene
  expression was determined by quantitative PCR in patients suffering from MDD (unmedicated
  n = ...'
disable_comments: true
---
Due to the high comorbidity of Parkinson's disease (PD) with major depressive disorder (MDD) and the involvement of sphingolipids in both conditions, we investigated the peripheral expression levels of three primarily PD-associated genes: α-synuclein (SNCA), lysosomal enzyme β-glucocerebrosidase (GBA1), and UDP-glucose ceramide glucosyltransferase (UGCG) in a sex-balanced MDD cohort. Normalized gene expression was determined by quantitative PCR in patients suffering from MDD (unmedicated n = ...